Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
News provided by Ro Apr 02, 2026, 13:02 ET The most effective GLP-1 medication is now available in a multi-dose pen NEW YORK, April 2, 2026 /PRNewswire/ -- Ro, the leading direct-to-patient healthcare company, today announced that it is working with Eli Lilly to launch the recently FDA-approved Zepbound (tirzepatide) KwikPen nationwide on its platform
Every conversion between milligrams, milliliters, and insulin syringe units
In patients not receiving SGLT-2 inhibitors at baseline, semaglutide was associated with cost savings of DKK 9,212 per person, with the higher cost of semaglutide treatment (DKK 70,524) entirely offset by the cost savings from avoiding kidney failure (DKK 98,041)
Your ovaries stopped producing hormonestirzepatide doesn't care
Your provider will help you determine when you have reached the dose that balances efficacy with tolerability
US$ 22.00
US$ 26.07
US$ 22.00
US$ 24.32
US$ 24.47
US$ 24.88
US$ 24.02
US$ 25.60
